Publication date: Dec 03, 2019
Purdue Pharma’s 1996 release of OxyContin led to increased opioid overdose deaths in the past two decades and was a primary cause of the opioid epidemic plaguing the country, according to a new study.
The authors estimated that if states without the triplicate program had the same level of exposure to OxyContin as states that had the triplicate prescribing program in place, they would have had 36% fewer drug overdose deaths and 44% fewer opioid overdose deaths on average in each year from 1996-2017.
-Overall, we find strong evidence that the marketing practices of OxyContin interacted with state-level policy conditions led to dramatically reduced overdose death rates in triplicate states,” the authors wrote.
- Chris Freind: Politicians addicted to blaming pharma for opioid crisis
- Dr. Andrew Kolodny MD on Responding to the Opioid Crisis
- Opioid Negotiations Fail to Produce Deal Just Before Trial
- White House Releases National Roadmap To Combat The Opioid Crisis
- Graph Theory Takes on the Opioid Epidemic
- Could Deep Brain Stimulation, A Last-Resort Treatment For Other Diseases, Be Answer To Opioid Addiction?